(MedPage Today) — The prevalence of cannabinoid hyperemesis syndrome (CHS) increased from 2016 to 2022, particularly among young adults, according to a cross-sectional study of emergency department (ED) visit data.
Among more than 188 million…
Source link : https://www.medpagetoday.com/emergencymedicine/emergencymedicine/118669
Author :
Publish date : 2025-11-24 16:07:00
Copyright for syndicated content belongs to the linked Source.
